These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 34315432)

  • 1. Extracellular volume-guided late gadolinium enhancement analysis for non-ischemic cardiomyopathy: The Women's Interagency HIV Study.
    Kato Y; Kizer JR; Ostovaneh MR; Lazar J; Peng Q; van der Geest RJ; Lima JAC; Ambale-Venkatesh B
    BMC Med Imaging; 2021 Jul; 21(1):116. PubMed ID: 34315432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive evaluation of macroscopic and microscopic myocardial fibrosis by cardiac MR: intra-individual comparison of gadobutrol versus gadoterate meglumine.
    Rahsepar AA; Ghasemiesfe A; Suwa K; Dolan RS; Shehata ML; Korell MJ; Naresh NK; Markl M; Collins JD; Carr JC
    Eur Radiol; 2019 Aug; 29(8):4357-4367. PubMed ID: 30617490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical value of dark-blood late gadolinium enhancement cardiovascular magnetic resonance without additional magnetization preparation.
    Holtackers RJ; Van De Heyning CM; Nazir MS; Rashid I; Ntalas I; Rahman H; Botnar RM; Chiribiri A
    J Cardiovasc Magn Reson; 2019 Jul; 21(1):44. PubMed ID: 31352900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of phase correction of late gadolinium enhancement images on scar signal quantification in patients with ischemic and non-ischemic cardiomyopathy.
    Stirrat J; Joncas SX; Salerno M; Drangova M; White J
    J Cardiovasc Magn Reson; 2015 Aug; 17(1):66. PubMed ID: 26248535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of sub-segmental visual scoring for the quantification of ischemic and nonischemic myocardial fibrosis using late gadolinium enhancement MRI.
    Fine NM; Tandon S; Kim HW; Shah DJ; Thompson T; Drangova M; White JA
    J Magn Reson Imaging; 2013 Dec; 38(6):1369-76. PubMed ID: 23559419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of late gadolinium enhancement image quality using a deep learning-based reconstruction algorithm and its influence on myocardial scar quantification.
    van der Velde N; Hassing HC; Bakker BJ; Wielopolski PA; Lebel RM; Janich MA; Kardys I; Budde RPJ; Hirsch A
    Eur Radiol; 2021 Jun; 31(6):3846-3855. PubMed ID: 33219845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional myocardial strain by cardiac magnetic resonance feature tracking for detection of scar in ischemic heart disease.
    Stathogiannis K; Mor-Avi V; Rashedi N; Lang RM; Patel AR
    Magn Reson Imaging; 2020 May; 68():190-196. PubMed ID: 32084516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of semi-automated scar quantification techniques using high-resolution, 3-dimensional late-gadolinium-enhancement magnetic resonance imaging.
    Rajchl M; Stirrat J; Goubran M; Yu J; Scholl D; Peters TM; White JA
    Int J Cardiovasc Imaging; 2015 Feb; 31(2):349-57. PubMed ID: 25307896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Convolutional neural network-based approach for segmentation of left ventricle myocardial scar from 3D late gadolinium enhancement MR images.
    Zabihollahy F; White JA; Ukwatta E
    Med Phys; 2019 Apr; 46(4):1740-1751. PubMed ID: 30734937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility study of a single breath-hold, 3D mDIXON pulse sequence for late gadolinium enhancement imaging of ischemic scar.
    Foley JRJ; Fent GJ; Garg P; Broadbent DA; Dobson LE; Chew PG; Brown LAE; Swoboda PP; Plein S; Higgins DM; Greenwood JP
    J Magn Reson Imaging; 2019 May; 49(5):1437-1445. PubMed ID: 30597661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic late gadolinium enhancement cardiac magnetic resonance for diagnosing myocardial scar.
    Abdula G; Nickander J; Sörensson P; Lundin M; Kellman P; Sigfridsson A; Ugander M
    Scand Cardiovasc J; 2018 Jun; 52(3):127-132. PubMed ID: 29544374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved Quantification of Myocardium Scar in Late Gadolinium Enhancement Images: Deep Learning Based Image Fusion Approach.
    Fahmy AS; Rowin EJ; Chan RH; Manning WJ; Maron MS; Nezafat R
    J Magn Reson Imaging; 2021 Jul; 54(1):303-312. PubMed ID: 33599043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High spatial resolution free-breathing 3D late gadolinium enhancement cardiac magnetic resonance imaging in ischaemic and non-ischaemic cardiomyopathy: quantitative assessment of scar mass and image quality.
    Bizino MB; Tao Q; Amersfoort J; Siebelink HJ; van den Bogaard PJ; van der Geest RJ; Lamb HJ
    Eur Radiol; 2018 Sep; 28(9):4027-4035. PubMed ID: 29626239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy and reproducibility of semi-automated late gadolinium enhancement quantification techniques in patients with hypertrophic cardiomyopathy.
    Mikami Y; Kolman L; Joncas SX; Stirrat J; Scholl D; Rajchl M; Lydell CP; Weeks SG; Howarth AG; White JA
    J Cardiovasc Magn Reson; 2014 Oct; 16(1):85. PubMed ID: 25315701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial Extracellular Volume Fraction Adds Prognostic Information Beyond Myocardial Replacement Fibrosis.
    Yang EY; Ghosn MG; Khan MA; Gramze NL; Brunner G; Nabi F; Nambi V; Nagueh SF; Nguyen DT; Graviss EA; Schelbert EB; Ballantyne CM; Zoghbi WA; Shah DJ
    Circ Cardiovasc Imaging; 2019 Dec; 12(12):e009535. PubMed ID: 31838882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of fast multi-slice and standard segmented techniques for detection of late gadolinium enhancement in ischemic and non-ischemic cardiomyopathy - a prospective clinical cardiovascular magnetic resonance trial.
    Muehlberg F; Arnhold K; Fritschi S; Funk S; Prothmann M; Kermer J; Zange L; von Knobelsdorff-Brenkenhoff F; Schulz-Menger J
    J Cardiovasc Magn Reson; 2018 Feb; 20(1):13. PubMed ID: 29458430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of extracellular volume fraction thresholds corresponding to myocardial late-gadolinium enhancement using cardiac magnetic resonance.
    Hwang SH; Choi EY; Park CH; Paek MY; Greiser A; Kim TH; Choi BW
    Int J Cardiovasc Imaging; 2014 Dec; 30 Suppl 2():137-44. PubMed ID: 25022430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance.
    Flett AS; Hasleton J; Cook C; Hausenloy D; Quarta G; Ariti C; Muthurangu V; Moon JC
    JACC Cardiovasc Imaging; 2011 Feb; 4(2):150-6. PubMed ID: 21329899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histopathological validation of semi-automated myocardial scar quantification techniques for dark-blood late gadolinium enhancement magnetic resonance imaging.
    Nies HMJM; Gommers S; Bijvoet GP; Heckman LIB; Prinzen FW; Vogel G; Van De Heyning CM; Chiribiri A; Wildberger JE; Mihl C; Holtackers RJ
    Eur Heart J Cardiovasc Imaging; 2023 Feb; 24(3):364-372. PubMed ID: 35723673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy: comparison of diagnostic performance in myocardial fibrosis between gadobutrol and gadopentetate dimeglumine.
    Liu D; Ma X; Liu J; Zhao L; Chen H; Xu L; Sun Z; Fan Z
    Int J Cardiovasc Imaging; 2017 Aug; 33(8):1191-1200. PubMed ID: 28289991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.